English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Breast cancer is a potentially fatal malignancy. This form of cancer is the most common among Western women. Breast cancer is a heterogeneous disease. Clinically, one can classify it based on biomarker expression (e.g. estrogen receptors, progesterone receptors, and HER-2 expression). Triple negative breast cancer is a unique type where the tumors are negative for estrogen receptors, progesterone receptors, and HER-2 expression which results in a more aggressive biology and treatment approach.

Referral Rate for, and Uptake of Genetic Testing in Women Diagnosed with Breast Cancer ≤ 35 and Triple Negative Breast Cancer (TNBC) ≤ 50